QC
DTIL icon

Quadrature Capital’s Precision BioSciences DTIL Stock Holding History

Quadrature Capital’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$178K Sell
32,281
-29,848
-48% -$138K ﹤0.01% 1143
2025
Q4 		$258K Buy
62,129
+48,158
+345% +$273K ﹤0.01% 893
2025
Q3 		$77.1K Buy
+13,971
New +$66.9K ﹤0.01% 913

Other funds holding DTIL

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Quadrature Capital's DTIL Position: Q1 2026 in Review

Quadrature Capital reduced its Precision BioSciences (DTIL) stake by 48% in Q1 2026, selling an estimated $138K and leaving 32,281 shares worth $178K. The position accounts for ﹤0.01% of the portfolio, ranked #1143.

Quadrature Capital first reported a position in DTIL in Q3 2025 and has held it in 3 quarters since. The position peaked at $258K in Q4 2025. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • Quadrature Capital held 32,281 shares of Precision BioSciences worth $178K as of Q1 2026.
  • Quadrature Capital sold 29,848 Precision BioSciences shares in Q1 2026, an estimated $138K.
  • Precision BioSciences made up ﹤0.01% of Quadrature Capital's portfolio in Q1 2026, its #1143 holding.
  • Quadrature Capital first reported a position in Precision BioSciences in Q3 2025 and has held it in 3 quarters since.
  • Quadrature Capital's Precision BioSciences position peaked at $258K in Q4 2025.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.